PolyPeptide Group AG (SWX: PPGN)

PolyPeptide Group AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	20.57	17.3	52.73	31.7	33.47	17.16
Accounts Receivable	1.46	0.81	1.81	0.25	0.32	1.56
Other Receivables	8.26	4.73	5.42	6.91	9.28	9.31
Property, Plant & Equipment	1,428	1,372	1,324	1,342	1,279	1,267
Other Intangible Assets	-	-	-	-	0	0.01
Long-Term Deferred Tax Assets	0.18	0.24	0.2	0.16	0.16	0.15
Total Assets	1,469	1,400	1,456	1,427	1,378	1,343
Current Income Taxes Payable	1.75	5.76	10.76	12.26	18.22	6.53
Common Stock	19	19	19	19	19	19
Retained Earnings	879.19	877.19	886.86	788.78	692.04	660.65
Treasury Stock	-35.77	-35.77	-35.79	-0.63	-	-9.98
Shareholders' Equity	869.02	867.31	878.81	809.74	710.63	666.15
Total Liabilities & Equity	1,469	1,400	1,456	1,427	1,378	1,343
Total Debt	460.47	382.39	394.89	435.33	475.57	516.26
Net Cash (Debt)	-439.89	-365.09	-342.16	-403.63	-442.1	-499.1
Net Cash Per Share	-47.73	-39.61	-36.78	-42.49	-47.02	-52.48
Filing Date Shares Outstanding	9.22	9.22	9.22	9.49	9.5	9.4
Total Common Shares Outstanding	9.22	9.22	9.22	9.49	9.5	9.4
Book Value Per Share	94.28	94.09	95.34	85.28	74.80	70.87
Tangible Book Value	869.02	867.31	878.81	809.74	710.63	666.13
Tangible Book Value Per Share	94.28	94.09	95.34	85.28	74.80	70.87

Source: S&P Capital IQ. Standard template. Financial Sources.